Literature DB >> 7532430

NADPH diaphorase staining suggests a transient and localized contribution of nitric oxide to host defence against an intracellular pathogen in situ.

I E Flesch1, J H Hess, S H Kaufmann.   

Abstract

Nitric oxide (NO) is formed constitutively in neurons by the constitutive enzyme NO synthase (cNOS) and acts as a neurotransmitter. It has already been shown that cNOS-containing neurons are identical to neurons staining for NADPH diaphorase and vice versa. Effector cells of the immune response produce high NO levels after appropriate stimulation and this NO is formed by inducible NO synthase (iNOS). The NO produced by macrophages is considered an important effector molecule of antimicrobial host defence. We have applied NADPH diaphorase staining for the detection of NO producing cells in situ during infection with an intracellular pathogen. Macrophages which produce NO in vitro are stained for NADPH diaphorase. Expression of iNOS mRNA and macrophage NADPH diaphorase staining was inhibited by iNOS-specific antisense oligonucleotides. These data suggest coincidental similarity between NADPH diaphorase activity and NO production by macrophages. Cells staining for NADPH diaphorase were identified in cryostat frozen sections of livers from mice infected with the intracellular pathogen, Listeria monocytogenes, and co-localized with cells labelled by MAC-1 mAbs. The purple-blue reaction product of NADPH diaphorase staining was visible in discrete granulomatous lesions but was absent from the liver parenchyma. Our results provide direct evidence for localized and transient participation of NO in antimicrobial immunity in the infected organ. This restriction may focus NO production to lesions, leaving unrelated tissue sites unaffected.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7532430     DOI: 10.1093/intimm/6.11.1751

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  8 in total

Review 1.  Innate immune gene polymorphisms in tuberculosis.

Authors:  Abul K Azad; Wolfgang Sadee; Larry S Schlesinger
Journal:  Infect Immun       Date:  2012-07-23       Impact factor: 3.441

2.  Native mRNA antisense-accessible sites library for the selection of antisense oligonucleotides, PNAs, and siRNAs.

Authors:  Huafeng Fang; Yuefei Shen; John-Stephen Taylor
Journal:  RNA       Date:  2010-05-24       Impact factor: 4.942

3.  Aberrant macrophage and neutrophil population dynamics and impaired Th1 response to Listeria monocytogenes in colony-stimulating factor 1-deficient mice.

Authors:  I Guleria; J W Pollard
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

4.  Activated pulmonary macrophages are insufficient for resistance against Pneumocystis carinii.

Authors:  R Hanano; K Reifenberg; S H Kaufmann
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

5.  Cytokine and protein markers of leprosy reactions in skin and nerves: baseline results for the North Indian INFIR cohort.

Authors:  Diana N J Lockwood; Lavanya Suneetha; Karuna Devi Sagili; Meher Vani Chaduvula; Ismail Mohammed; Wim van Brakel; W C Smith; Peter Nicholls; Sujai Suneetha
Journal:  PLoS Negl Trop Dis       Date:  2011-12-13

6.  Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis.

Authors:  T Fehr; G Schoedon; B Odermatt; T Holtschke; M Schneemann; M F Bachmann; T W Mak; I Horak; R M Zinkernagel
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

7.  The role of nitric oxide in mycobacterial infections.

Authors:  Chul-Su Yang; Jae-Min Yuk; Eun-Kyeong Jo
Journal:  Immune Netw       Date:  2009-04-30       Impact factor: 6.303

8.  Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis.

Authors:  S Nicholson; M da G Bonecini-Almeida; J R Lapa e Silva; C Nathan; Q W Xie; R Mumford; J R Weidner; J Calaycay; J Geng; N Boechat; C Linhares; W Rom; J L Ho
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.